Vomaris Innovations

Executive Summary

Vomaris Innovations is a US-based medical device company specializing in advanced wound care through its proprietary V.DOX bioelectric antimicrobial dressing technology. Founded in 2008 and headquartered in Chandler, Arizona, the company aims to reduce infection risk and accelerate healing without antibiotics by mimicking the body's natural electrical healing processes. Currently at a pre-clinical stage, Vomaris has not yet commercialized any products but holds potential in the growing wound care market, which is driven by rising chronic wound prevalence and antimicrobial resistance concerns. The company's technology platform differentiates itself by offering a non-pharmacological approach to infection control, which could reduce reliance on antibiotics and address critical unmet needs in clinical settings. However, with limited public information on funding, partnerships, or regulatory progress, the company remains an early-stage investment opportunity with high technical risk but significant upside if clinical validation is achieved.

Upcoming Catalysts (preview)

• Q4 2026Initiation of first-in-human clinical trial for V.DOX dressing60% success
• Q2 2027FDA breakthrough device designation or 510(k) submission40% success
• TBDStrategic partnership with a larger wound care company25% success